AB1329 Biologic agents and risk of serious infections in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results by integrating ten-year (X2006–2015) administrative databases in the italian region of friuli venezia giulia

Abstract

BackgroundSerious infections are a major concern for patients considering biologic agents for rheumatoid arthritis (RA) or psoriatic arthritis (PsA) or ankylosing spondylitis (AS). Evidence from meta-analyses is consistent with an...